Exponent (EXPO)
(Delayed Data from NSDQ)
$106.26 USD
+2.57 (2.48%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $106.43 +0.17 (0.16%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth C Momentum C VGM
Income Statements
Fiscal Year end for Exponent, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 537 | 513 | 466 | 400 | 417 |
Cost Of Goods | 40 | 49 | 31 | 21 | 26 |
Gross Profit | 497 | 464 | 435 | 378 | 391 |
Selling & Adminstrative & Depr. & Amort Expenses | 386 | 323 | 326 | 295 | 306 |
Income After Depreciation & Amortization | 111 | 141 | 109 | 83 | 85 |
Non-Operating Income | 25 | -9 | 17 | 14 | 19 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 136 | 132 | 126 | 97 | 104 |
Income Taxes | 36 | 30 | 25 | 14 | 22 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 100 | 102 | 101 | 83 | 82 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 100 | 102 | 101 | 83 | 82 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 120 | 148 | 115 | 90 | 91 |
Depreciation & Amortization (Cash Flow) | 9 | 7 | 6 | 7 | 6 |
Income After Depreciation & Amortization | 111 | 141 | 109 | 83 | 85 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 51.64 | 52.28 | 53.33 | 53.32 | 53.88 |
Diluted EPS Before Non-Recurring Items | 1.94 | 1.96 | 1.71 | 1.55 | 1.53 |
Diluted Net EPS (GAAP) | 1.94 | 1.96 | 1.90 | 1.55 | 1.53 |
Fiscal Year end for Exponent, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 140.54 | 144.93 | 122.90 | 133.34 | 140.22 |
Cost Of Goods | 8.10 | 7.73 | 9.03 | 8.38 | 10.57 |
Gross Profit | 132.43 | 137.21 | 113.87 | 124.96 | 129.65 |
SG&A, R&D, and Dept/Amort Expenses | 96.69 | 106.49 | 95.48 | 91.03 | 99.78 |
Income After SG&A, R&D, and Dept/Amort Expenses | 35.74 | 30.72 | 18.39 | 33.93 | 29.87 |
Non-Operating Income | 3.94 | 9.71 | 11.69 | 0.08 | 6.38 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 39.68 | 40.42 | 30.09 | 34.02 | 36.25 |
Income Taxes | 10.46 | 10.28 | 9.16 | 9.48 | 10.51 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 29.23 | 30.14 | 20.93 | 24.54 | 25.75 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 29.23 | 30.14 | 20.93 | 24.54 | 25.75 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 51.52 | 51.42 | 51.45 | 51.65 | 51.69 |
Diluted EPS Before Non-Recurring Items | 0.57 | 0.59 | 0.41 | 0.48 | 0.50 |
Diluted Net EPS (GAAP) | 0.57 | 0.59 | 0.40 | 0.48 | 0.50 |